AIDS: HIV drugs boost prevention hopes
Heterosexuals who take daily AIDS drugs reduce the risk of being infected by the human immunodeficiency virus (HIV) by nearly two-thirds, ground-breaking studies said on Wednesday.
Campaigners hailed what they described as a powerful new weapon in the three-decade war against AIDS.
"This is a major scientific breakthrough which reconfirms the essential role that antiretroviral medicine has to play in the AIDS response," Michel Sidibe, executive director of the UN agency UNAIDS said.
"These studies could help us to reach the tipping point in the HIV epidemic."
A trial called Partners PrEP, conducted by the University of Washington, followed 4,758 "sero-discordant" heterosexual couples -- in which one person had HIV and the other was uninfected -- in Kenya and Uganda.
In the group receiving tenofovir, there were 62 percent fewer infections compared with the placebo group.
In the tenofovir/emtricitabine group, there were 73 percent fewer infections over counterparts taking the placebo.
The results were so remarkable that safety monitors recommended the probe be stopped early, for to continue it would have been unethical.
The second trial, conducted by the US Centers for Disease Control and Prevention (CDC), followed 1,219 uninfected men and women in Botswana who received either placebo or the tenofovir/emtricitabine combination.
They are the first trials to show that so-called pre-exposure prophylaxis, or PrEP, can work among heterosexuals.
Last November a study, conducted among sero-discordant homosexual men, found a reduction of 44 percent in risk among uninfected partners who took HIV drugs.
In contrast, a smaller-scale trial, whose preliminary results were published earlier this year, found that PrEP did not protect heterosexual women.
In May, a big study conducted among sero-discordant heterosexual couples in Africa showed early use of drugs by the infected partner slashed the risk of transmitting HIV to the other partner by 96 percent.
Put together, these trials add massively to the argument that the world's AIDS pandemic can be slowed by wider distribution of antiretrovirals, said activists.
"These results are tremendously exciting and confirm that we are at pivotal period," said Mitchell Warren, executive director of US advocacy group AVAC.
"Now is the time to include ARV-based prevention in national plans, applications to the Global Fund to Fight AIDS, Tuberculosis and Malaria and donor priorities.
"(...) We need ambitious pilot and demonstration projects to guide programmatic design, along with national and international guidance on how best to use ARVs (antiretrovirals) as lifesaving prevention tools," he said.
The International AIDS Society, which is hosting a major conference in Rome from Sunday, said data from the two trials was "compelling" and "adds to the cascade of evidence."
But it also highlighted the looming debate about using drugs designed for treatment in the role of prevention.
Antiretrovirals are the famous "cocktail" of drugs, first introduced in 1996, that helped turn the tide against AIDS.
They suppress HIV in the body but do not eradicate it completely.
As a result, they reduce the risk of infection through contact with body fluids, although they are not a cure and taking them can carry inflict toxic side effects.
In addition, there is a potentially hefty financial cost if the pills are taken daily for prevention, although the price has fallen to as little as 25 US cents per tablet.
The "treatment as prevention" strategy has risen alongside male circumcision as new options in the global HIV/AIDS pandemic, which has claimed around 30 million lives over the past three decades.
More than 33 million people are living with the AIDS virus, according to estimates for 2009 released last year by UNAIDS.
(c) 2011 AFP
- VOICE study will continue as it considers what action to take after results of two trials Jul 13, 2011 | not rated yet | 0
- Oral pill trial to halt HIV in women is stopped Apr 19, 2011 | not rated yet | 0
- Pivotal study in Africa finds that HIV medications prevent HIV infection Jul 13, 2011 | not rated yet | 0
- Antiretroviral drugs may protect against sexual transmission of HIV Feb 05, 2008 | not rated yet | 0
- Drug stops HIV among hetero couples, not just gays Jul 13, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies ...
HIV & AIDS 3 hours ago | 5 / 5 (1) | 0
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...
HIV & AIDS May 22, 2013 | not rated yet | 0
Canadian health authorities lifted Wednesday what was effectively a ban on gay men giving blood, announcing new rules making men who have not had sex with men in the past five years eligible.
HIV & AIDS May 22, 2013 | not rated yet | 1
Top AIDS scientists were optimistic Wednesday of finding a cure for the disease that has claimed 30 million lives—but said it might not work for all people.
HIV & AIDS May 22, 2013 | not rated yet | 0
The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...
HIV & AIDS May 21, 2013 | not rated yet | 0
(HealthDay)—Type 2 diabetes is more aggressive in children than adults, with signs of serious complications seen just a few years after diagnosis, new research finds.
40 minutes ago | not rated yet | 0
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
3 hours ago | 4.7 / 5 (3) | 0 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
7 hours ago | 5 / 5 (2) | 0 |
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
7 hours ago | 5 / 5 (1) | 1 |
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
7 hours ago | not rated yet | 0 |
A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...
8 hours ago | 4.9 / 5 (7) | 0 |